{
    "key": "2016-0022",
    "name": "Hep B- Dose #4 administered < 8 weeks after dose #3.",
    "cdcTestId": "2016-0022",
    "changedInVersion": "3.3",
    "dateAdded": "2016-12-02T00:00:00",
    "dateUpdated": "2020-06-18T08:17:34.04",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-03-23T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-05-25T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-07-14T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-10T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "All Valid: Forecast Test",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Recommended based on interval",
    "generalDescription": "This test cases describes when a patient is administered dose #4 at less than 8 weeks after dose #3  and at least 16 weeks after dose #1 that the dose is considered to be valid. The series is complete.",
    "patient": {
        "dob": "2019-12-23T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-03-23T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-05-25T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-07-14T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-10T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ]
    },
    "reasonForChange": "v3.3: Updated the evaluation type to All Valid: Forecast Test",
    "testcaseName": "Hep B- Dose #4 administered < 8 weeks after dose #3.",
    "vaccineGroup": "HepB"
}